CNBC | Researchers shift focus to prevention of Alzheimer's The Globe and Mail The demand for a drug to stop or slow the progression of Alzheimer's is urgent. Every year, 25,000 Canadians are diagnosed with various forms of dementia, one of the most common of which is Alzheimer's disease. And the total number of Canadians living ... Big Alzheimer's research roadblock: Federal government Diabetes Drug Could Boost Brain Power in Alzheimer's Disease A Diabetes Drug May Finally Be the Answer to Cure Alzheimer's Disease |